Fulgent Genetics Balance Sheet Health
Financial Health criteria checks 4/6
Fulgent Genetics has a total shareholder equity of $1.1B and total debt of $2.9M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $1.2B and $103.2M respectively.
Key information
0.3%
Debt to equity ratio
US$2.91m
Debt
Interest coverage ratio | n/a |
Cash | US$305.70m |
Equity | US$1.13b |
Total liabilities | US$103.24m |
Total assets | US$1.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: FLGT *'s short term assets ($386.5M) exceed its short term liabilities ($75.9M).
Long Term Liabilities: FLGT *'s short term assets ($386.5M) exceed its long term liabilities ($27.3M).
Debt to Equity History and Analysis
Debt Level: FLGT * has more cash than its total debt.
Reducing Debt: FLGT *'s debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: FLGT *'s debt is well covered by operating cash flow (1451.3%).
Interest Coverage: Insufficient data to determine if FLGT *'s interest payments on its debt are well covered by EBIT.